These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 12019888)
1. Pharmacokinetics of a high-generation dendrimer-Gd-DOTA. Bryant LH; Jordan EK; Bulte JW; Herynek V; Frank JA Acad Radiol; 2002 May; 9 Suppl 1():S29-33. PubMed ID: 12019888 [No Abstract] [Full Text] [Related]
2. Arterial concentration profiles of two blood pool agents and Gd-DOTA after intravenous injection in rabbits. Corot CA; Violas X; Robert P; Port M Acad Radiol; 2002 May; 9 Suppl 1():S137-9. PubMed ID: 12019850 [No Abstract] [Full Text] [Related]
3. Comparison of Gd-BOPTA and Gd-DOTA for peripheral CE-MRA: a double-blind clinical study. Lohr HA; Froehlich JM; Pfyffer M; Bader CW; Zollikofer CL; Wentz KU Acad Radiol; 2002 Aug; 9 Suppl 2():S421-4. PubMed ID: 12188295 [No Abstract] [Full Text] [Related]
4. P760: a new gadolinium complex characterized by a low rate of interstitial diffusion. Port M; Corot C; Raynal I; Dencausse A; Schaefer M; Rousseaux O; Simonot C; Devoldere L; Lin J; Foulon M; Bourrinet P; Bonnemain B; Meyer D Acad Radiol; 2002 May; 9 Suppl 1():S17-9. PubMed ID: 12019859 [No Abstract] [Full Text] [Related]
5. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats. Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826 [TBL] [Abstract][Full Text] [Related]
6. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent. Xiao Y; Xue R; You T; Li X; Pei F Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395 [TBL] [Abstract][Full Text] [Related]
7. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents. Erdene K; Nakajima T; Kameo S; Khairinisa MA; Lamid-Ochir O; Tumenjargal A; Koibuchi N; Koyama H; Tsushima Y Jpn J Radiol; 2017 Oct; 35(10):568-573. PubMed ID: 28730467 [TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI. Baumann D; Rudin M Magn Reson Imaging; 2000 Jun; 18(5):587-95. PubMed ID: 10913720 [TBL] [Abstract][Full Text] [Related]
9. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results. Port M; Corot C; Rousseaux O; Raynal I; Devoldere L; Idée JM; Dencausse A; Le Greneur S; Simonot C; Meyer D MAGMA; 2001 May; 12(2-3):121-7. PubMed ID: 11390267 [TBL] [Abstract][Full Text] [Related]
10. Gd-DOTA renal pharmacokinetic study by factor analysis in transplanted human kidney and in phantom. Corréas JM; Chabriais J; Melki P; Helenon O; Di Paola M; Di Paola R; Moreau JF Invest Radiol; 1994 Jun; 29 Suppl 2():S174-6. PubMed ID: 7928220 [No Abstract] [Full Text] [Related]
12. MR angiography with a new rapid clearance blood pool agent (P792): initial experience in rabbits. Ruehm SG; Schmitz-Cristina H; Violas X; Corot C; Debatin JF Acad Radiol; 2002 Aug; 9 Suppl 2():S407-8. PubMed ID: 12188291 [No Abstract] [Full Text] [Related]
13. Evaluation of MR contrast agents with high relaxivity and reduced interstitial diffusion for contrast material-enhanced MRA and myocardial perfusion studies. Canet Soulas EP; Marchand B; Casali C; Corot C; Douek P; Revel D Acad Radiol; 2002 May; 9 Suppl 1():S88-91. PubMed ID: 12019906 [No Abstract] [Full Text] [Related]
14. Pharmacokinetics and biodistribution study of self-assembled Gd-micelles demonstrating blood-pool contrast enhancement for MRI. Vorobiev V; Babič A; Crowe LA; Van De Looij Y; Lenglet S; Thomas A; Helm L; Vallée JP; Allémann E Int J Pharm; 2019 Sep; 568():118496. PubMed ID: 31279053 [TBL] [Abstract][Full Text] [Related]
15. Oval window transport of Gd-dOTA from rat middle ear to vestibulum and scala vestibuli visualized by in vivo magnetic resonance imaging. Zou J; Poe D; Ramadan UA; Pyykkö I Ann Otol Rhinol Laryngol; 2012 Feb; 121(2):119-28. PubMed ID: 22397222 [TBL] [Abstract][Full Text] [Related]
16. Hepatic transport of gadobenate dimeglumine in TR-rats. de Haën C; Lorusso V; Tirone P Acad Radiol; 1996 Aug; 3 Suppl 2():S452-4. PubMed ID: 8796627 [No Abstract] [Full Text] [Related]
17. A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: kinetic study on a C6 rat glioma model. Fonchy E; Lahrech H; François-Joubert A; Dupeyre R; Benderbous S; Corot C; Farion R; Rubin C; Décorps M; Rémy C J Magn Reson Imaging; 2001 Aug; 14(2):97-105. PubMed ID: 11477666 [TBL] [Abstract][Full Text] [Related]
18. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits. Ruehm SG; Christina H; Violas X; Corot C; Debatin JF Magn Reson Med; 2002 Nov; 48(5):844-51. PubMed ID: 12417999 [TBL] [Abstract][Full Text] [Related]
19. P 792 (Vistarem). Drugs R D; 2002; 3(5):305. PubMed ID: 12455150 [No Abstract] [Full Text] [Related]
20. MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium. Jacquier A; Wendland M; Do L; Robert P; Corot C; Higgins CB; Saeed M Contrast Media Mol Imaging; 2008; 3(3):112-9. PubMed ID: 18548477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]